Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
26,684,722
-
Share change
-
+453,981
-
Total reported value
-
$784,490,600
-
Put/Call ratio
-
42%
-
Price per share
-
$29.40
-
Number of holders
-
104
-
Value change
-
-$1,610,368
-
Number of buys
-
61
-
Number of sells
-
60
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2014
As of 30 Jun 2014,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,684,722 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, ORBIMED ADVISORS LLC, WASATCH ADVISORS INC, FRANKLIN RESOURCES INC, NEXT CENTURY GROWTH INVESTORS LLC, FMR LLC, VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
103
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.